SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2000

Study Completion Date

March 31, 2004

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

cisplatin

DRUG

irinotecan hydrochloride

DRUG

semaxanib

Trial Locations (1)

Arthur G. James Cancer Hospital - Ohio State University, Columbus

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT00006000 - SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter